HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - liping+zhang
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
In-vivo System to Interrogate the Functions of Mucous Membranes and Identify Mucin/Glycan Mimetics and JAK/STAT Inhibitors for the Treatment of Diseases of the Oral Cavity and Digestive Tract
This technology includes a Drosophila mutant strain that can be used as an in vivo model for diseases of the oral cavity and digestive tract (Sjogren's syndrome, colitis, colon cancer, inflammatory bowel disease), where the mucous membrane is disrupted or non-functional. This mutant lacks a mucous membrane and displays epithelial cell damage, uncontrolled...
Published: 12/26/2024
|
Inventor(s):
Liping Zhang
,
Kelly Ten Hagen
Keywords(s):
FUNCTIONS
,
IDENTIFY
,
Inhibitors
,
Interrogate
,
Jak/STAT
,
MEMBRANES
,
MIMETICS
,
Mucin/glycan
,
Mucous
,
System
,
Vivo
,
VPXXXX
,
WIXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
,
Application > Therapeutics
,
Application > Research Materials
,
TherapeuticArea > Cardiology
Novel Kinase Inhibitory Thiazines
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 12/20/2024
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application
,
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Rare / Neglected Diseases
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing
Reverse Thiazine Kinase Inhibitors
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 12/19/2024
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Rare / Neglected Diseases
,
Collaboration Sought > Licensing
Novel Kinase Inhibitory Aplithianines
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 12/20/2024
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Therapeutics
,
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Rare / Neglected Diseases
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum